Stock Analysts’ upgrades for Monday, August 28th:

Adva Optical Netwo (NASDAQ:ADVOF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $8.25 target price on the stock. According to Zacks, “ADVA Optical Networking SE develops, manufactures and sells optical and Ethernetbased networking solutions. It serves telecommunications service providers, private companies, universities and government agencies. ADVA Optical Networking SE is headquartered in Munich, Germany. “

Ashford Hospitality Prime (NYSE:AHP) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Ashford Hospitality Prime, Inc. is a real estate investment trust. It is focused on investing in high RevPAR full-service and urban select-service hotels and resorts located predominantly in domestic and international gateway markets. Ashford Hospitality Prime, Inc. is based in Dallas, Texas. “

Sphere 3D Corp. (NASDAQ:ANY) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Sphere 3D Corporation is a virtualization technology solution provider. The Company is engaged in the development, and sale of Sphere 3D’s Glassware 2.0 ultra-thin client technology, that allows access to third party software on any Cloud connected device. Sphere 3D also develops V3 systems appliances, a series of servers that are used for virtualization; and provides Desktop Cloud Orchestrator software, which allows administrators to manage local, cloud hosted, or hybrid virtual desktop deployments. It caters to the cloud computing market. Sphere 3D Inc. is based in Mississauga, Canada. “

Anavex Life Sciences Corp. (NASDAQ:AVXL) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $4.75 price target on the stock. According to Zacks, “ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company’s proprietary SIGMACEPTOR Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways. “

Banco Bilbao Vizcaya Argentaria SA (NASDAQ:BBVA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $10.00 price target on the stock. According to Zacks, “Banco Bilbao Vizcaya is engaged in a wide variety of banking, financial and related activities in Spain. “

Blue Capital Reinsurance Holdings (NYSE:BCRH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Blue Capital Holdings Ltd. is a reinsurance holding company. It offers collateralized reinsurance in the property catastrophe market. Blue Capital Holdings Ltd. is based in Bermuda. “

Biohaven Pharmaceutical Holding Co (NASDAQ:BHVN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company’s pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States. “

BT Group PLC (NYSE:BT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $21.00 price target on the stock. According to Zacks, “BT is one of the world’s leading providers of communications services and solutions, serving customers in more than 170 countries. Its principal activities include the provision of networked IT services globally; local, national and international telecommunications services to its customers for use at home, at work and on the move; broadband and internet products and services and converged fixed/mobile products and services. BT consists principally of four lines of business: BT Global Services, BT Retail, BT Wholesale and Openreach. British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group plc and encompasses virtually all businesses and assets of the BT Group. BT Group plc is listed on stock exchanges in London and New York. “

British American Tobacco p.l.c. (NYSE:BTI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $69.00 target price on the stock. According to Zacks, “British American Tobacco is the holding company of a group of companies which manufacture, market and sell tobacco products. “

Compania Cervecerias Unidas, (NYSE:CCU) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $31.00 target price on the stock. According to Zacks, “Compañía Cervecerías Unidas S. A. (CCU) has successfully positioned itself as a Chilean multinational beverage company, with diversified businesses and operations focused on the Southern Cone of South America. CCU is active in the beer industry in Chile, where it operates the country’s leading brewery, and in Argentina, where it holds third place in the market. In the non-alcoholic beverages sector, it is Chile’s second-largest bottler of carbonated beverages and the leader in the mineral water market. It has winemaking operations in Argentina and in Chile. “

Compugen (NASDAQ:CGEN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen’s expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery. “

China Telecom Corp (NYSE:CHA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $55.00 target price on the stock. According to Zacks, “China Telecom Corporation is a state-owned telecommunications company in China. They operate local telephone networks in ten provinces in China. They operate domestic and international fixed-line networks and infrastructure including wireless local loop, as well as telecom network-based voice, data, video, multimedia and information services. They are also engaged in international telecom service settlement and expand into overseas markets. “

Costamare (NYSE:CMRE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Costamare Inc. operates as a containership owner chartering its vessels to liner companies. The Company deploys its containership fleet principally under multi-year time charters with leading liner companies that operate regularly scheduled routes between large commercial ports. It also provides a range of shipping services, such as technical support and maintenance, insurance consulting, financial and accounting services. Costamare Inc. is headquartered in Athens, Greece. “

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.